Return On Assets of Spyre Therapeutics, Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Spyre Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Spyre Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -27%, a 47% increase year-over-year.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2024 was -43%, a 73% increase from 2023.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2023 was -160%, a 69% decline from 2022.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2022 was -95%, a 99% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Spyre Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -27% +24% +47% 01 Jul 2025 30 Sep 2025
Q2 2025 -39% +12% +23% 01 Apr 2025 30 Jun 2025
Q1 2025 -41% +73% +64% 01 Jan 2025 31 Mar 2025
Q4 2024 -43% +118% +73% 01 Oct 2024 31 Dec 2024
Q3 2024 -51% +154% +75% 01 Jul 2024 30 Sep 2024
Q2 2024 -51% +187% +79% 01 Apr 2024 30 Jun 2024
Q1 2024 -114% -17% -18% 01 Jan 2024 31 Mar 2024
Q4 2023 -160% -65% -69% 01 Oct 2023 31 Dec 2023
Q3 2023 -205% -118% -135% 01 Jul 2023 30 Sep 2023
Q2 2023 -238% -156% -191% 01 Apr 2023 30 Jun 2023
Q1 2023 -97% -35% -57% 01 Jan 2023 31 Mar 2023
Q4 2022 -95% -47% -99% 01 Oct 2022 31 Dec 2022
Q3 2022 -87% -42% -93% 01 Jul 2022 30 Sep 2022
Q2 2022 -82% -40% -95% 01 Apr 2022 30 Jun 2022
Q1 2022 -61% -12% -25% 01 Jan 2022 31 Mar 2022
Q4 2021 -48% +10% +18% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% +22% +32% 01 Jul 2021 30 Sep 2021
Q2 2021 -42% +37% +47% 01 Apr 2021 30 Jun 2021
Q1 2021 -49% +38% +44% 01 Jan 2021 31 Mar 2021
Q4 2020 -58% +15% +20% 01 Oct 2020 31 Dec 2020
Q3 2020 -67% +1% +1.1% 01 Jul 2020 30 Sep 2020
Q2 2020 -79% -16% -26% 01 Apr 2020 30 Jun 2020
Q1 2020 -87% -28% -46% 01 Jan 2020 31 Mar 2020
Q4 2019 -73% -9% -14% 01 Oct 2019 31 Dec 2019
Q3 2019 -68% -12% -21% 01 Jul 2019 30 Sep 2019
Q2 2019 -63% -11% -21% 01 Apr 2019 30 Jun 2019
Q1 2019 -60% -10% -20% 01 Jan 2019 31 Mar 2019
Q4 2018 -64% -19% -43% 01 Oct 2018 31 Dec 2018
Q3 2018 -56% -15% -36% 01 Jul 2018 30 Sep 2018
Q2 2018 -52% -15% -41% 01 Apr 2018 30 Jun 2018
Q1 2018 -50% -16% -48% 01 Jan 2018 31 Mar 2018
Q4 2017 -44% -10% -29% 01 Oct 2017 31 Dec 2017
Q3 2017 -41% -5% -13% 01 Jul 2017 30 Sep 2017
Q2 2017 -37% 01 Apr 2017 30 Jun 2017
Q1 2017 -34% 01 Jan 2017 31 Mar 2017
Q4 2016 -34% 01 Oct 2016 31 Dec 2016
Q3 2016 -36% 01 Jul 2016 30 Sep 2016

Spyre Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -43% +118% +73% 01 Jan 2024 31 Dec 2024
2023 -160% -65% -69% 01 Jan 2023 31 Dec 2023
2022 -95% -47% -99% 01 Jan 2022 31 Dec 2022
2021 -48% +10% +18% 01 Jan 2021 31 Dec 2021
2020 -58% +15% +20% 01 Jan 2020 31 Dec 2020
2019 -73% -9% -14% 01 Jan 2019 31 Dec 2019
2018 -64% -19% -43% 01 Jan 2018 31 Dec 2018
2017 -44% -10% -29% 01 Jan 2017 31 Dec 2017
2016 -34% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.